{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:26:13Z","timestamp":1792517173775,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of this study was to determine how Stathmin-1 and Heat Shock Protein 27 (HSP27) can be used as adjunctive biomarkers to differentiate high-grade dysplasia from benign\/reactive lesions in cervical tissues. In addition, we aimed to see if any of these markers can differentiate endometrial from endocervical adenocarcinomas.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Fifty cases including benign cervical tissue, low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), adenocarcinoma in situ of the endocervix, invasive endocervical adenocarcinoma, and endometrial adenocarcinoma were selected. Stathmin-1 and HSP27 immunohistochemistry (IHC) were performed for each case and the results were compared to the previously available p16 IHC stains.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>p16 stained positively in 100% of HSIL, endocervical adenocarcinoma in situ, and invasive endocervical cases. Stathmin-1 stained positively in 43% of HSIL and 90% of endocervical adenocarcinoma in situ and all invasive endocervical cases. Stathmin-1 and p16 were negative in all benign cervical samples. Stathmin-1, HSP27, and p16 stained 100% of LSIL cases. HSP27 stained indiscriminately, including 100% of benign cervical tissue. 87% of the endometrial adenocarcinomas stained positively for p16, Stathmin-1, and HSP27.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>p16 remains superior to both Stathmin-1 and HSP27 in differentiating dysplasia from benign, reactive changes of the cervix.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-021-01144-w","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T09:09:18Z","timestamp":1632128958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia"],"prefix":"10.1186","volume":"16","author":[{"given":"Sofia","family":"Liou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neshat","family":"Nilforoushan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuna","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda A.","family":"Moatamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"1144_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/PAS.0b013e3182753f5a","volume":"37","author":"BE Howitt","year":"2013","unstructured":"Howitt BE, Nucci MR, Drapkin R, Crum CP, Hirsch MS. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity. Am J Surg Pathol. 2013;37:89\u201397. https:\/\/doi.org\/10.1097\/PAS.0b013e3182753f5a.","journal-title":"Am J Surg Pathol"},{"key":"1144_CR2","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/PAS.0b013e3181e8b2c4","volume":"34","author":"MT Galgano","year":"2010","unstructured":"Galgano MT, Castle PE, Atkins KA, Brix WK, Nassau SR, Stoler MH. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol. 2010;34:1077\u201387. https:\/\/doi.org\/10.1097\/PAS.0b013e3181e8b2c4.","journal-title":"Am J Surg Pathol"},{"key":"1144_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1517\/14728222.2011.620951","volume":"15","author":"B Belletti","year":"2011","unstructured":"Belletti B, Baldassarre G. Stathmin: a protein with many tasks. New biomarker and potential target in cancer. Expert Opin Ther Targets. 2011;15:1249\u201366. https:\/\/doi.org\/10.1517\/14728222.2011.620951.","journal-title":"Expert Opin Ther Targets"},{"key":"1144_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13000-021-01072-9","volume":"16","author":"C Hui","year":"2021","unstructured":"Hui C, Bai H, Liu J, Lu X, Wang S, Zhang Z, et al. Accuracy of HPV E6\/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions. Diagn Pathol. 2021;16:13. https:\/\/doi.org\/10.1186\/s13000-021-01072-9.","journal-title":"Diagn Pathol"},{"key":"1144_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1309\/AJCPO0WY1VIFCYDC","volume":"132","author":"P Conesa-Zamora","year":"2009","unstructured":"Conesa-Zamora P, Domenech-Peris A, Orantes-Casado FJ, Ortiz-Reina S, Sahuquillo-Frias L, Acosta-Ortega J, et al. Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study. Am J Clin Pathol. 2009;132:378\u201390. https:\/\/doi.org\/10.1309\/AJCPO0WY1VIFCYDC.","journal-title":"Am J Clin Pathol"},{"key":"1144_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/cncy.21264","volume":"121","author":"NA Moatamed","year":"2013","unstructured":"Moatamed NA, Rao JY, Alexanian S, Cobarrubias M, Levin M, Lu D, et al. ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens. Cancer Cytopathol. 2013;121:320\u20138. https:\/\/doi.org\/10.1002\/cncy.21264.","journal-title":"Cancer Cytopathol"},{"key":"1144_CR7","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1016\/j.humpath.2013.06.011","volume":"44","author":"NA Moatamed","year":"2013","unstructured":"Moatamed NA, Vergara-Lluri ME, Lu D, Apple SK, Kerkoutian S, Rao JY. Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions. Hum Pathol. 2013;44:2509\u201317. https:\/\/doi.org\/10.1016\/j.humpath.2013.06.011.","journal-title":"Hum Pathol"},{"key":"1144_CR8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00432-008-0520-1","volume":"135","author":"W Xi","year":"2009","unstructured":"Xi W, Rui W, Fang L, Ke D, Ping G, Hui-Zhong Z. Expression of stathmin\/op18 as a significant prognostic factor for cervical carcinoma patients. J Cancer Res Clin Oncol. 2009;135:837\u201346. https:\/\/doi.org\/10.1007\/s00432-008-0520-1.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1144_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3109\/07357900009012204","volume":"18","author":"DK Price","year":"2000","unstructured":"Price DK, Ball JR, Bahrani-Mostafavi Z, Vachris JC, Kaufman JS, Naumann RW, et al. The phosphoprotein Op18\/stathmin is differentially expressed in ovarian cancer. Cancer Invest. 2000;18:722\u201330. https:\/\/doi.org\/10.3109\/07357900009012204.","journal-title":"Cancer Invest"},{"key":"1144_CR10","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1073\/pnas.0806514106","volume":"106","author":"HB Salvesen","year":"2009","unstructured":"Salvesen HB, Carter SL, Mannelqvist M, Dutt A, Getz G, Stefansson IM, et al. Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proc Natl Acad Sci U S A. 2009;106:4834\u20139. https:\/\/doi.org\/10.1073\/pnas.0806514106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1144_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.humpath.2008.06.010","volume":"40","author":"A Ono","year":"2009","unstructured":"Ono A, Kumai T, Koizumi H, Nishikawa H, Kobayashi S, Tadokoro M. Overexpression of heat shock protein 27 in squamous cell carcinoma of the uterine cervix: a proteomic analysis using archival formalin-fixed, paraffin-embedded tissues. Hum Pathol. 2009;40:41\u20139. https:\/\/doi.org\/10.1016\/j.humpath.2008.06.010.","journal-title":"Hum Pathol"},{"key":"1144_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.bjc.6605992","volume":"104","author":"MI Lomnytska","year":"2011","unstructured":"Lomnytska MI, Becker S, Bodin I, Olsson A, Hellman K, Hellstrom AC, et al. Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value. Br J Cancer. 2011;104:110\u20139. https:\/\/doi.org\/10.1038\/sj.bjc.6605992.","journal-title":"Br J Cancer"},{"key":"1144_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s13577-011-0040-1","volume":"25","author":"A Tozawa-Ono","year":"2012","unstructured":"Tozawa-Ono A, Yoshida A, Yokomachi N, Handa R, Koizumi H, Kiguchi K, et al. Heat shock protein 27 and p16 immunohistochemistry in cervical intraepithelial neoplasia and squamous cell carcinoma. Hum Cell. 2012;25:24\u20138. https:\/\/doi.org\/10.1007\/s13577-011-0040-1.","journal-title":"Hum Cell"},{"key":"1144_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/cas.12417","volume":"105","author":"A Watanabe","year":"2014","unstructured":"Watanabe A, Suzuki H, Yokobori T, Tsukagoshi M, Altan B, Kubo N, et al. Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma. Cancer Sci. 2014;105:690\u20136. https:\/\/doi.org\/10.1111\/cas.12417.","journal-title":"Cancer Sci"},{"key":"1144_CR15","first-page":"363","volume":"26","author":"E Ioachin","year":"2005","unstructured":"Ioachin E. Immunohistochemical tumour markers in endometrial carcinoma. Eur J Gynaecol Oncol. 2005;26:363\u201371.","journal-title":"Eur J Gynaecol Oncol"},{"key":"1144_CR16","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.14670\/HH-29.1161","volume":"29","author":"KS Makela","year":"2014","unstructured":"Makela KS, Haapasalo JA, Ilvesaro JM, Parkkila S, Paavonen T, Haapasalo HK. Hsp27 and its expression pattern in diffusely infiltrating astrocytomas. Histol Histopathol. 2014;29:1161\u20138. https:\/\/doi.org\/10.14670\/HH-29.1161.","journal-title":"Histol Histopathol"},{"key":"1144_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s0960-9776(02)00290-4","volume":"12","author":"E Ioachim","year":"2003","unstructured":"Ioachim E, Tsanou E, Briasoulis E, Batsis C, Karavasilis V, Charchanti A, et al. Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer. Breast. 2003;12:111\u20139. https:\/\/doi.org\/10.1016\/s0960-9776(02)00290-4.","journal-title":"Breast"},{"key":"1144_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s13402-012-0079-3","volume":"35","author":"K Bauer","year":"2012","unstructured":"Bauer K, Nitsche U, Slotta-Huspenina J, Drecoll E, von Weyhern CH, Rosenberg R, et al. High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer. Cell Oncol (Dordr). 2012;35:197\u2013205. https:\/\/doi.org\/10.1007\/s13402-012-0079-3.","journal-title":"Cell Oncol (Dordr)"},{"key":"1144_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1034\/j.1600-0463.2003.1110411.x","volume":"111","author":"GO Elpek","year":"2003","unstructured":"Elpek GO, Karaveli S, Simsek T, Keles N, Aksoy NH. Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries. APMIS. 2003;111:523\u201330. https:\/\/doi.org\/10.1034\/j.1600-0463.2003.1110411.x.","journal-title":"APMIS"},{"key":"1144_CR20","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/cncr.11594","volume":"98","author":"T Lebret","year":"2003","unstructured":"Lebret T, Watson RW, Molinie V, O\u2019Neill A, Gabriel C, Fitzpatrick JM, et al. Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma. Cancer. 2003;98:970\u20137. https:\/\/doi.org\/10.1002\/cncr.11594.","journal-title":"Cancer"},{"key":"1144_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.yexmp.2012.09.001","volume":"94","author":"A Ghosh","year":"2013","unstructured":"Ghosh A, Lai C, McDonald S, Suraweera N, Sengupta N, Propper D, et al. HSP27 expression in primary colorectal cancers is dependent on mutation of KRAS and PI3K\/AKT activation status and is independent of TP53. Exp Mol Pathol. 2013;94:103\u20138. https:\/\/doi.org\/10.1016\/j.yexmp.2012.09.001.","journal-title":"Exp Mol Pathol"},{"key":"1144_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/PAS.0000000000000974","volume":"42","author":"AM Mills","year":"2018","unstructured":"Mills AM, Coppock JD, Willis BC, Stoler MH. HPV E6\/E7 mRNA In Situ Hybridization in the Diagnosis of Cervical Low-grade Squamous Intraepithelial Lesions (LSIL). Am J Surg Pathol. 2018;42:192\u2013200. https:\/\/doi.org\/10.1097\/PAS.0000000000000974.","journal-title":"Am J Surg Pathol"},{"key":"1144_CR23","volume-title":"Monoclonal Anti-Stathmin-1 and Anti-HSP27 are Reliable Biomarkers for Identification of Cervical Intraepithelial Neoplasia and Cervical Squamous Carcinoma","author":"G Yang","year":"2020","unstructured":"Yang G, Lacey M, Knoll T, Minasyan A, Gordon J. Monoclonal Anti-Stathmin-1 and Anti-HSP27 are Reliable Biomarkers for Identification of Cervical Intraepithelial Neoplasia and Cervical Squamous Carcinoma. 2020. https:\/\/www.cellmarque.com\/cms\/_downloads\/marketing\/Academia\/ACADEMIA_Stathmin_HSP27.pdf. Accessed 14 July 2021."},{"key":"1144_CR24","unstructured":"Ventana-System-Inc. CINtec\u00ae Histology Interpretation guide for immunohistochemistry staining of cervical punch biopsy specimens. 2917. http:\/\/www.hsl-ad.com\/newsletters\/CINtec-Histology-Interpretation-Guide.pdf. Accessed 14 July 2021."},{"key":"1144_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000353863","volume":"36","author":"P Eusebi","year":"2013","unstructured":"Eusebi P. Diagnostic accuracy measures. Cerebrovasc Dis. 2013;36:267\u201372. https:\/\/doi.org\/10.1159\/000353863.","journal-title":"Cerebrovasc Dis"},{"key":"1144_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/IGC.0b013e31825cc8ee","volume":"23","author":"MW Jones","year":"2013","unstructured":"Jones MW, Onisko A, Dabbs DJ, Elishaev E, Chiosea S, Bhargava R. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors. Int J Gynecol Cancer. 2013;23:380\u20134. https:\/\/doi.org\/10.1097\/IGC.0b013e31825cc8ee.","journal-title":"Int J Gynecol Cancer"},{"key":"1144_CR27","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1097\/PAS.0b013e3181971fdd","volume":"33","author":"A Yemelyanova","year":"2009","unstructured":"Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Am J Surg Pathol. 2009;33:914\u201324. https:\/\/doi.org\/10.1097\/PAS.0b013e3181971fdd.","journal-title":"Am J Surg Pathol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01144-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-021-01144-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01144-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T09:15:31Z","timestamp":1632129331000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-021-01144-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1186\/s13000-021-01144-w","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"assertion":[{"value":"31 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board at the David Geffen School of Medicine at UCLA has approved this study (IRB# 17\u2013001254).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to the publication of the work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}